Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2003
05/15/2003US20030092005 Sequences determination of preferential nucleotide sequences; obtain nucleotide sequences, denatrue, incubate with primers and polymerases, amplify, recover products, determine nucleotide sequence of sample
05/15/2003US20030092002 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092000 Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
05/15/2003US20030091998 Association of beta2-adrenergic receptor haplotypes with drug response
05/15/2003US20030091997 Chemical inhibitors of mismatch repair
05/15/2003US20030091994 Diagnosis via detection hybridization pattern of chromosomal probes; biopsies
05/15/2003US20030091993 Use and screening method for an aberrant gene product-operating substance
05/15/2003US20030091992 Nutrients broth for use in the cytological and molecular analysis
05/15/2003US20030091991 Gene detecting method and test kit
05/15/2003US20030091990 Methods and compositions involving thymidine phosphorylase as a marker for HIV infection, aids progression, and drug resistance
05/15/2003US20030091988 Methods, kits and compositions for the identification of nucleic acids electrostatically bound to matrices
05/15/2003US20030091987 Materials and methods for detecting, preventing, and treating retroviral infection
05/15/2003US20030091986 Identification of expressed genes using phage display
05/15/2003US20030091985 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
05/15/2003US20030091984 Methods for judging resistance to the onset of bovine leukemia
05/15/2003US20030091981 Kit for use in the deetction of genes associated with xylogenesis
05/15/2003US20030091980 Detection of psychoactive drugs in in vitro neuronal tissue sample; obtain neuronal tissue sample, monitor oscillation of electrical impulses, compare impulses, detect presence of psychoactive drugs
05/15/2003US20030091979 Apparatus for use in the generation of muscle tissue
05/15/2003US20030091978 Assay for glucocorticoid receptor signalling pathway
05/15/2003US20030091977 Assessment method
05/15/2003US20030091975 Multiple determinants for metabolic phenotypes
05/15/2003US20030091974 Detecting compounds capable of exhausting mast cells; culture mast cells, incubate with modulator, measure mast cell death, classify compound
05/15/2003US20030091598 Compounds and methods for the diagnosis and treatment of Babesia infection
05/15/2003US20030091594 CD4-independent HIV envelope proteins as vaccines and therapeutics
05/15/2003US20030091587 Bactericides, fungicides, viricides
05/15/2003US20030091582 Autoimmune diseases; antitumor agents; antiallergens
05/15/2003US20030091572 Methods and compositions for the treatment and diagnosis of pain disorders using 2047
05/15/2003US20030091571 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/15/2003US20030091570 Analgesics; antiinflammatory agents; analyzing drug as to ability to modulation gene expression
05/15/2003US20030091569 Methods for the treatment of carcinoma
05/15/2003US20030091567 Antiinflammatory agents; anticancer agents
05/15/2003US20030091562 Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
05/15/2003US20030091538 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
05/15/2003US20030091537 Anticancer agents; gene coding immunomoderator cytokine protein
05/15/2003US20030091476 Comprises microscopic vessels; for microarrays of DNA and RNA oligonucleotides, peptides, oligosacchrides, and phospholipids; genetic mapping; drug screening
05/15/2003US20030090959 Apparatus and method for mixing specimens in vials
05/15/2003US20030089731 Article dispensing apparatus and method
05/15/2003US20030088963 Container uncapping mechanism and method
05/15/2003CA2736469A1 Compositions, methods and kits for determining the presence of mycoplasma pneumoniae and/or mycoplasma genitalium in a test sample
05/15/2003CA2466502A1 Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
05/15/2003CA2466497A1 Protease assay for therapeutic drug monitoring
05/15/2003CA2466421A1 Method for generating idiosyncratic catalytic fingerprint of a sample, processing of said print and systems therefor
05/15/2003CA2466334A1 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof
05/15/2003CA2466138A1 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003CA2466088A1 Method for selecting genetically transformed cells
05/15/2003CA2465961A1 Isolation and purification of nucleic acids
05/15/2003CA2465951A1 Transcription factor stress-related polypeptides and methods of use in plants
05/15/2003CA2465949A1 Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof
05/15/2003CA2465921A1 Novel compositions and methods for cancer
05/15/2003CA2465849A1 Methods of storing and/or delivering an oligomer and/or polymer applied on a support, and supports thereof
05/15/2003CA2465798A1 Method in the form of a dry rapid test for detecting nucleic acids
05/15/2003CA2465763A1 Method for detecting bacteria associated with parodontitis and tooth decay
05/15/2003CA2465731A1 Screening for hepatitis c virus entry inhibitors
05/15/2003CA2465724A1 Engineering of leader peptides for the secretion of recombinant proteins in bacteria
05/15/2003CA2465239A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2465220A1 System for detecting biological materials in a sample
05/15/2003CA2464766A1 Detection of predisposition to osteoporosis
05/15/2003CA2464765A1 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003CA2464626A1 Method for the in vitro synthesis of short double stranded rnas
05/15/2003CA2464007A1 Methods for treating ocular neovascular diseases
05/15/2003CA2463703A1 Reaction chambers containing complex stable reagent formulations and test kit for detection and isolation of pathogenic microbial nucleic acids
05/15/2003CA2462653A1 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
05/15/2003CA2462617A1 Method of identifying energy transfer sensors for analytes
05/15/2003CA2462505A1 Asymmetric pcr with nuclease-free polymerase or nuclease-resistant molecular beacons
05/15/2003CA2448162A1 Hiv-1 vpr interactions with mitochondrial apoptosis inducing factor and methods of using the same
05/15/2003CA2429147A1 Radiosensitivity enhancers, radiosensitivity-enhancing nucleic acids and proteins in cancer radiotherapy
05/14/2003EP1310800A2 Functional assay for agonist activation of neuroreceptors
05/14/2003EP1310799A1 In vitro screening for ligands of the estrogen receptor
05/14/2003EP1310793A1 Substrate activation kit and method of detecting dna or the like by using the same
05/14/2003EP1310790A2 Multi-column affinity detection system
05/14/2003EP1310787A1 Electrochemical cells
05/14/2003EP1310571A2 A Method of detecting and/or identifying adeno-associated virus (AVV) sequences and isolating novel sequences identified thereby
05/14/2003EP1310570A1 Methods and compositions to identify swine genetically resistant to F18 E. Coli associated diseases
05/14/2003EP1310569A2 Method and test kit for the detection of genes
05/14/2003EP1310568A2 Hybridization of probes
05/14/2003EP1310567A2 Nucleic acid array
05/14/2003EP1310566A2 Method for the identification of a recombinant nucleic acid
05/14/2003EP1310565A1 A process for detecting nucleic acid target molecules using an enzyme-linked probe capture assay and a kit therefor
05/14/2003EP1310556A2 Composition and methods for the identification of lung tumor cells
05/14/2003EP1310555A2 Oligonucleotide modulation of protein kinase C
05/14/2003EP1310553A1 Method of estimating the genotype of fertility recovery locus to rice bt type male fertility cytoplasm
05/14/2003EP1310552A2 Posh nucleic acids, polypeptides and related methods
05/14/2003EP1310512A2 Hcv core protein sequences
05/14/2003EP1310510A2 Topologically segregated, encoded solid phase libraries
05/14/2003EP1310507A2 Novel peptide nucleic acids
05/14/2003EP1310166A1 Transgenic non-human mammal and method of constructing the same, animal disease model and method of clarifying gene function
05/14/2003EP1309922A2 System and method for characterising and sequencing polymers
05/14/2003EP1309871A2 High throughput method and kit
05/14/2003EP1309870A2 Direct selection of protein complexes relevant to the physiological or diagnostic context of a biological specimen
05/14/2003EP1309869A1 Designing and screening random libraries of compounds
05/14/2003EP1309863A1 Methods for manipulating moieties in microfluidic systems
05/14/2003EP1309858A2 Interaction of colloid-immobilized species with species on non-colloidal structures
05/14/2003EP1309857A2 A method for detecting a lipoprotein-acute phase protein complex
05/14/2003EP1309729A1 Use of an imaging photoelectric flat sensor for evaluating biochips and imaging method therefor
05/14/2003EP1309728A2 Method for the highly parallel analysis of polymorphisms
05/14/2003EP1309727A2 Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer's disease
05/14/2003EP1309726A2 Rna sequence-specific mediators of rna interference
05/14/2003EP1309725A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human fetal liver
05/14/2003EP1309724A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and bt 474 cells
05/14/2003EP1309723A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and hbl 100 cells
1 ... 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 ... 3003